Clinical Trial Update: De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients

View source ↗

Summary

A clinical trial to evaluate de-escalation of neoadjuvant chemotherapy regimens with targeted therapy in HER2-positive breast cancer patients; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shu Wang | Conditions: HER2-positive Breast Cancer | Status: RECRUITING